$MBX 4 SEC Filings

Filed On	Filing
22 Oct 2026	Form 4: Radovich Peter, Director Granted 18,200 Stock option (right to buy)
05 Aug 2026	Form 4: Azoulay Salomon, Chief Medical Officer Sold 370 shares ($24.3K)
04 Aug 2026	Form 4: Smither John W, Chief Financial Officer Received 28,000 shares as a grant or award · Granted 130,000 Stock option (right to buy)
04 Aug 2026	Form 4: Hoerter Steven L., Director Received 71,000 shares as a grant or award · Granted 331,000 Stock option (right to buy)
05 Jun 2026	Form 4: Mathers Edward T, Director Granted 12,500 Stock option (right to buy)
05 Jun 2026	Form 4: Heron Patrick J, Director Granted 12,500 Stock option (right to buy)
05 Jun 2026	Form 4: Stelzer Laurie, Director Granted 12,500 Stock option (right to buy)
05 Jun 2026	Form 4: Hoerter Steven L., Director Granted 12,500 Stock option (right to buy)
05 Jun 2026	Form 4: Ryder Steven, Director Granted 12,500 Stock option (right to buy)
05 Jun 2026	Form 4: Aynechi Tiba, Director Granted 12,500 Stock option (right to buy)
05 Jun 2026	Form 4: Pescovitz Ora H., Director Granted 12,500 Stock option (right to buy)
11 May 2026	Form 4: Azoulay Salomon, Chief Medical Officer Received 70,003 shares by exercise or conversion ($815K) · Sold 70,003 shares ($2.69M) · Acquired 70,003 Stock option (right to buy) (Option Exercise/Conversion)
08 May 2026	Form 4: Azoulay Salomon, Chief Medical Officer Sold 231 shares ($6.82K)
08 May 2026	Form 4: Hawryluk P. Kent, Director Sold 607 shares ($17.9K)
04 May 2026	Form 4: Hoerter Steven L., Director Received 11,938 shares as a grant or award · Granted 74,249 Stock option (right to buy)
16 Mar 2026	Form 4: Hawryluk P. Kent, Director Bought 18,500 shares ($526K)
27 Feb 2026	Form 4: Hawryluk P. Kent, Director Received 28,768 shares by exercise or conversion ($460K)
03 Feb 2026	Form 4: Azoulay Salomon, Chief Medical Officer Received 15,000 shares as a grant or award · Granted 70,000 Stock option (right to buy)
03 Feb 2026	Form 4: Bartram Richard, Chief Financial Officer Received 15,000 shares as a grant or award · Granted 70,000 Stock option (right to buy)
03 Feb 2026	Form 4: Hawryluk P. Kent, Director Received 35,250 shares as a grant or award · Granted 164,500 Stock option (right to buy)

Comments